Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€21.85
12.04.22
-
12.04.23
-9.84%
12.04.23

Saftman 
12.04.22 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€52.93
11.04.22
€40.00
11.04.23
4.10%
03.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
11.04.22 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.75
11.04.22
-
11.04.23
-41.07%
08.06.22

Could be worthwhile Investment >10% per year
melinda 
11.04.22 50%
sell
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€0.000
06.04.23
-22.00%
18.04.22

Could be worthwhile Investment >10% per year
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
dimontalban 
06.04.22 50%
sell
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€1.00
06.04.23
-22.00%
18.04.22

Probably not worthwhile Investment
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
Marianka 
06.04.22 70%
sell
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.76
04.04.22
€0.000
04.04.23
-33.28%
18.04.22

EBIT decline > 20% expected
Revenue decline > 20% expected
Very low/no dividend yield expected
Sustainability is not important
Marianka 
04.04.22 50%
sell
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.76
04.04.22
€0.000
04.04.23
-35.27%
02.06.22

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline > 20% expected
overvalued
dimontalban 
04.04.22 40%
buy
Paul Hartmann AG

Start price
Target price
Perf. (%)
€326.00
04.04.22
-
04.04.23
-31.60%
05.04.23

DirectorDealer 
04.04.22 50%
sell
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.28
03.04.22
-
03.04.23
-98.20%
04.04.23

Probably not worthwhile Investment
Lokrim 
03.04.22 20%
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€40.88
03.04.22
-
03.04.23
39.43%
04.04.23

Could be worthwhile Investment >10% per year
Lokrim 
03.04.22 20%
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€184.00
02.04.22
€200.00
02.04.23
-15.22%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
skatcup 
02.04.22 50%
buy
Carmat

Start price
Target price
Perf. (%)
€14.84
30.03.22
€18.00
30.03.23
-17.45%
22.10.22

Could be worthwhile Investment >10% per year
melinda 
30.03.22 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.60
30.03.22
-
30.03.23
-55.74%
20.11.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
30.03.22 0%
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€8.06
29.03.22
€15.30
29.03.23
-17.24%
30.03.23

Could be worthwhile Investment >10% per year
melinda 
29.03.22 50%
buy
iRhythm Technologies Inc

Start price
Target price
Perf. (%)
€137.00
29.03.22
-
29.03.23
-16.79%
29.03.23

Saftman 
29.03.22 50%
buy
Evolent Health Inc

Start price
Target price
Perf. (%)
€28.40
29.03.22
-
29.03.23
-0.70%
29.03.23

Saftman 
29.03.22 50%
buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€25.40
28.03.22
-
28.03.23
25.20%
02.04.22

Risky Investment
Global_Player 
28.03.22 50%
sell
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€59.50
22.03.22
-
22.03.23
-20.59%
31.03.22

Risky Investment
Global_Player 
22.03.22 50%
buy
Agenus Inc.

Start price
Target price
Perf. (%)
€2.54
22.03.22
-
22.03.23
-42.13%
21.05.22

Lector 
22.03.22 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€64.50
22.03.22
-
22.03.23
-43.57%
23.03.23

Saftman 
22.03.22 50%
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€7.65
21.03.22
€11.00
21.03.23
-7.01%
22.03.23

Could be worthwhile Investment >10% per year
Higher risks for its business
tbackenh 
21.03.22 50%
sell
Bovie Medical Corp

Start price
Target price
Perf. (%)
€6.45
20.03.22
-
20.03.23
-8.53%
28.05.22

Risky Investment
Lokrim 
20.03.22 20%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€21.29
16.03.22
€56.00
16.03.23
149.27%
17.03.23

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
16.03.22 60%
sell
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€81.03
15.03.22
-
15.03.23
-14.84%
20.03.22

Could be worthwhile Investment >10% per year
Vassago1 
15.03.22 50%
sell
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€20.53
14.03.22
€14.00
14.03.23
3.70%
16.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
14.03.22 60%